Search Results

SLEDAI-2K for a 30-day window.

• Authors : Touma, Z.¹; Urowitz, M. B.¹; Gladman, D. D.¹

Subjects: *SYSTEMIC lupus erythematosus; *SPONTANEOUS cancer regression; *PATIENTSTORONTO (Ont.); ONTARIOUNIVERSITY of Toronto

• Source: Lupus. Jan2010, Vol. 19 Issue 1, p49-50. 2p. 1 Color Photograph, 1 Chart.

Record details

Natural history of dysplasia of the uterine cervix.

• Authors : Holowaty P; Faculty of Medicine, Department of Public Health Sciences, University of Toronto, Ontario, Canada. ; Miller AB

Subjects: Uterine Cervical Dysplasia/Uterine Cervical Dysplasia/Uterine Cervical Dysplasia/*pathology ; Uterine Cervical Neoplasms/Uterine Cervical Neoplasms/Uterine Cervical Neoplasms/*pathology; Chi-Square Distribution

• Source: Journal of the National Cancer Institute [J Natl Cancer Inst] 1999 Feb 03; Vol. 91 (3), pp. 252-8.Publisher: Oxford University Press Country of Publication: United States NLM ID: 7503089 Publication Model: Print Cited Medium: Print ISSN:

Record details

Trough serum infliximab: a predictive factor of clinical outcome for infliximab treatment in acute ulcerative colitis.

Subjects: *INFLIXIMAB; *COLITIS treatment; *ULCERATIVE colitisONTARIO

• Source: Inflammatory Bowel Disease Monitor. 2010, Vol. 10 Issue 4, p131-132. 2p.

Record details

Natural history of dysplasia of the uterine cervix.

• Authors : Holowaty, Philippa; Miller, Anthony B.; Rohan, Tom

Subjects: CERVIX uteri; DYSPLASIA; WOMENCANADA; ONTARIO

• Source: JNCI: Journal of the National Cancer Institute; 02/03/99, Vol. 91 Issue 3, p252-258, 7p

Record details